RA0793

antibody from Oursmab

Targeting: TNFSF15 MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0793

Provider

Oursmab

Product name

Tulisokibart (Biosimilar Reference Antibody) (TNFSF15)

Antibody type

Monoclonal

Description

Tulisokibart is a fully human IgG1 kappa monoclonal antibody targeting TNF-like ligand 1A (TL1A, also known as TNFSF15), a cytokine involved in mucosal inflammation and fibrosis. It binds to TL1A to block its interaction with death receptor 3 (DR3), thereby inhibiting downstream pro-inflammatory and pro-fibrotic signaling. It is being developed for the treatment of inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Tulisokibart (Biosimilar Reference Antibody) (TNFSF15)-RA0793-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.